Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

SRPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.70%

Insider Buying (Last 12 Months): $4,955,684.40

Insider Selling (Last 12 Months): $11,647,905.42

Sarepta Therapeutics Insider Trading History Chart

Sarepta Therapeutics Share Price & Price History

^$109.71

▼ -1.15 (-1.04%)

As of 11/21/2024 10:35 AM ET

Days: 30 | 90 | 365

Trump said you could learn something from this man

From Wide Moat Research | Ad

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

Sarepta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Ian Michael Estepan	CFO	Sell	5,985	$137.36	$822,099.60	33,946
8/16/2024	Michael Andrew Chambers	Director	Buy	37,038	$133.80	$4,955,684.40	284,034
6/25/2024	Ryan Edward Brown	EVP	Sell	38,957	$161.61	$6,295,840.77	17,129
6/24/2024	Bilal Arif	Insider	Sell	7,859	$163.08	$1,281,645.72	21,261
5/2/2024	Dallan Murray	Insider	Sell	3,635	$140.00	$508,900.00	18,125
3/11/2024	Kathryn Jean Boor	Director	Sell	761	$122.93	$93,549.73	7,516
3/8/2024	Hans Rudolf Wigzell	Director	Sell	15,000	$123.25	$1,848,750.00	22,840
3/5/2024	Stephen Mayo	Director	Sell	3,135	$122.96	$385,479.60	6,621
3/1/2024	Bilal Arif	Insider	Sell	2,000	$128.84	$257,680.00	26,836
3/1/2024	Ian Michael Estepan	CFO	Sell	1,200	$128.30	$153,960.00	39,114
11/3/2023	Douglas S. Ingram	CEO	Buy	25,225	$79.36	$2,001,856.00	390,307
11/3/2023	Richard Barry	Director	Buy	50,000	$78.81	$3,940,500.00	140,000
8/14/2023	Michael Andrew Chambers	Director	Buy	9,979	$109.47	$1,092,401.13	246,996
8/10/2023	Michael Andrew Chambers	Director	Buy	34,867	$106.15	$3,701,132.05	213,331
8/4/2023	Hans Rudolf Wigzell	Director	Sell	15,000	$106.72	$1,600,800.00	20,994
11/17/2022	Stephen Mayo	Director	Sell	858	$109.92	$94,311.36	6,387
9/14/2022	Michael Andrew Chambers	Director	Buy	57,100	$104.43	$5,962,953.00	108,178
8/19/2022	Michael Andrew Chambers	Director	Buy	46,170	$108.28	$4,999,287.60	51,078
11/24/2021	Louise Rodino-Klapac	Insider	Buy	3,780	$79.33	$299,867.40

Tesla Execs are Freaking Out

From Angel Publishing | Ad

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.

SEC Filings (Institutional Ownership Changes) for Sarepta Therapeutics (NASDAQ:SRPT)

86.68% of Sarepta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sarepta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Teachers Retirement System of The State of Kentucky	30,070	$3.76M	0.0%	-0.4%	0.031%
11/18/2024	Sunbelt Securities Inc.	284	$35K	0.0%	+446.2%	0.000%
11/16/2024	Geode Capital Management LLC	1,696,354	$211.91M	0.0%	+2.7%	1.776%
11/15/2024	M&T Bank Corp	4,462	$0.56M	0.0%	+8.5%	0.005%
11/15/2024	Public Employees Retirement System of Ohio	32,892	$4.11M	0.0%	-4.7%	0.034%
11/15/2024	Y Intercept Hong Kong Ltd	7,947	$0.99M	0.1%	-79.0%	0.008%
11/15/2024	Main Management ETF Advisors LLC	5,432	$0.68M	0.0%	N/A	0.006%
11/15/2024	Orion Portfolio Solutions LLC	9,758	$1.22M	0.0%	-1.8%	0.010%
11/15/2024	National Bank of Canada FI	387	$48K	0.0%	-94.9%	0.000%
11/15/2024	Castleark Management LLC	3,340	$0.42M	0.0%	-10.7%	0.003%
11/15/2024	Kovitz Investment Group Partners LLC	2,814	$0.32M	0.0%	+36.7%	0.003%
11/15/2024	Wellington Management Group LLP	2,726,613	$340.53M	0.1%	+32.3%	2.854%
11/15/2024	Two Sigma Advisers LP	128,034	$15.99M	0.0%	-78.9%	0.134%
11/15/2024	Soros Fund Management LLC	206,583	$25.80M	0.4%	N/A	0.216%
11/15/2024	Stifel Financial Corp	37,207	$4.65M	0.0%	+99.3%	0.039%
11/15/2024	Point72 Asset Management L.P.	36,855	$4.60M	0.0%	-24.7%	0.039%
11/15/2024	Polar Asset Management Partners Inc.	12,700	$1.59M	0.0%	-11.8%	0.013%
11/15/2024	Ikarian Capital LLC	54,176	$6.77M	0.9%	-73.5%	0.057%
11/15/2024	Jacobs Levy Equity Management Inc.	753,845	$94.15M	0.4%	+9.2%	0.789%
11/15/2024	Janus Henderson Group PLC	4,358,511	$544.41M	0.3%	+14.2%	4.563%
11/15/2024	HighTower Advisors LLC	39,333	$4.87M	0.0%	-20.8%	0.041%
11/15/2024	Garden State Investment Advisory Services LLC	16,936	$2.12M	0.6%	N/A	0.018%
11/15/2024	Erste Asset Management GmbH	636,065	$79.43M	1.0%	N/A	0.666%
11/14/2024	Bellevue Group AG	344,348	$43.01M	0.7%	+36.5%	0.360%
11/14/2024	Edgestream Partners L.P.	18,459	$2.31M	0.1%	N/A	0.019%
11/14/2024	Point72 Europe London LLP	6,983	$0.87M	0.1%	N/A	0.007%
11/14/2024	PDT Partners LLC	39,024	$4.87M	0.4%	+10.8%	0.041%
11/14/2024	Fred Alger Management LLC	286,879	$35.83M	0.2%	-9.9%	0.300%
11/14/2024	Braidwell LP	370,400	$46.26M	1.3%	-99.1%	0.388%
11/14/2024	Eventide Asset Management LLC	272,954	$34.09M	0.6%	+19.4%	0.286%
11/14/2024	Captrust Financial Advisors	3,871	$0.48M	0.0%	+15.2%	0.004%
11/14/2024	Taconic Capital Advisors LP	5,000	$0.62M	0.3%	N/A	0.005%
11/14/2024	Summit Partners Public Asset Management LLC	138,118	$17.25M	0.5%	+547.9%	0.145%
11/14/2024	Alkeon Capital Management LLC	633,845	$79.16M	0.1%	+13.4%	0.664%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	268,203	$33.50M	0.0%	-11.0%	0.281%
11/14/2024	Ally Bridge Group NY LLC	72,000	$8.99M	4.8%	-2.0%	0.075%
11/14/2024	MetLife Investment Management LLC	53,327	$6.66M	0.0%	-1.1%	0.056%
11/14/2024	Blueshift Asset Management LLC	2,096	$0.26M	0.1%	N/A	0.002%
11/13/2024	Finepoint Capital LP	133,535	$16.68M	1.2%	+0.5%	0.140%
11/13/2024	Quantbot Technologies LP	1,900	$0.24M	0.0%	N/A	0.002%
11/13/2024	The Manufacturers Life Insurance Company	74,778	$9.34M	0.0%	-16.5%	0.078%
11/13/2024	Qsemble Capital Management LP	2,489	$0.31M	0.1%	N/A	0.003%
11/13/2024	Fisher Asset Management LLC	18,155	$2.27M	0.0%	+1.3%	0.019%
11/13/2024	Daiwa Securities Group Inc.	3,929	$0.49M	0.0%	+13.8%	0.004%
11/12/2024	Centaurus Financial Inc.	1,251	$0.16M	0.0%	-10.7%	0.001%
11/12/2024	Larson Financial Group LLC	8,749	$1.09M	0.1%	+1,649.8%	0.009%
11/12/2024	Algert Global LLC	69,206	$8.64M	0.2%	+10.6%	0.072%
11/12/2024	Eagle Asset Management Inc.	371,435	$45.17M	0.2%	-8.5%	0.389%
11/12/2024	Charles Schwab Investment Management Inc.	611,749	$76.40M	0.0%	+1.2%	0.640%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	78,244	$9.77M	0.0%	+30.1%	0.082%
11/8/2024	Commerce Bank	2,016	$0.25M	0.0%	+15.7%	0.002%
11/8/2024	Fifth Third Wealth Advisors LLC	3,643	$0.46M	0.0%	-5.1%	0.004%
11/7/2024	Braun Stacey Associates Inc.	103,012	$12.87M	0.5%	+4.9%	0.108%
11/7/2024	Thrivent Financial for Lutherans	624,888	$78.04M	0.1%	-3.1%	0.655%
11/7/2024	AM Squared Ltd	1,400	$0.18M	0.4%	+600.0%	0.001%
11/6/2024	Mutual of America Capital Management LLC	51,542	$6.44M	0.1%	-4.8%	0.054%
11/6/2024	Mizuho Markets Americas LLC	399,065	$49.84M	1.0%	+22.3%	0.418%
11/6/2024	Simplify Asset Management Inc.	193,010	$24.11M	1.1%	+84.6%	0.202%
11/6/2024	CIBC Asset Management Inc	2,712	$0.34M	0.0%	+3.3%	0.003%
11/6/2024	Huntington National Bank	291	$36K	0.0%	+150.9%	0.000%
11/6/2024	Oppenheimer Asset Management Inc.	4,457	$0.56M	0.0%	+3.4%	0.005%
11/5/2024	Victory Capital Management Inc.	66,279	$8.28M	0.0%	-20.2%	0.069%
11/5/2024	Aigen Investment Management LP	1,823	$0.23M	0.0%	-81.4%	0.002%
11/5/2024	Prime Capital Investment Advisors LLC	8,654	$1.08M	0.0%	+3.0%	0.009%
11/5/2024	Platform Technology Partners	2,462	$0.31M	0.1%	+15.2%	0.003%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	1,700	$0.21M	0.0%	+21.4%	0.002%
11/5/2024	WCM Investment Management LLC	10,917	$1.36M	0.0%	+32.5%	0.011%
11/4/2024	State of New Jersey Common Pension Fund D	32,698	$4.08M	0.0%	-0.7%	0.034%
11/4/2024	Crossmark Global Holdings Inc.	7,161	$0.89M	0.0%	+16.1%	0.008%
11/4/2024	Sigma Planning Corp	10,849	$1.36M	0.0%	-3.2%	0.011%
11/1/2024	Assetmark Inc.	39,025	$4.87M	0.0%	+230.6%	0.041%
11/1/2024	Fiera Capital Corp	359,996	$44.96M	0.1%	-5.9%	0.377%
10/31/2024	Principal Financial Group Inc.	267,037	$33.35M	0.0%	-26.4%	0.283%
10/31/2024	Ironsides Asset Advisors LLC	2,605	$0.33M	0.1%	N/A	0.003%
10/31/2024	Advisor Resource Council	1,763	$0.22M	0.1%	N/A	0.002%
10/30/2024	Amalgamated Bank	46,473	$5.80M	0.0%	-4.6%	0.049%
10/30/2024	AlphaCentric Advisors LLC	18,000	$2.25M	1.7%	+140.0%	0.019%
10/30/2024	QRG Capital Management Inc.	1,969	$0.25M	0.0%	N/A	0.002%
10/29/2024	Emerald Advisers LLC	8,338	$1.04M	0.0%	+94.9%	0.009%
10/29/2024	Van ECK Associates Corp	68,176	$8.85M	0.0%	-18.0%	0.072%
10/29/2024	Emerald Mutual Fund Advisers Trust	1,018	$0.13M	0.0%	N/A	0.001%
10/29/2024	Silvant Capital Management LLC	28,009	$3.50M	0.2%	+11.8%	0.030%
10/28/2024	Gladstone Institutional Advisory LLC	83,300	$10.40M	0.5%	+47.7%	0.088%
10/28/2024	US Bancorp DE	6,549	$0.82M	0.0%	+4.3%	0.007%
10/25/2024	Pinnacle Associates Ltd.	91,951	$11.48M	0.2%	+83.5%	0.097%
10/25/2024	First Trust Direct Indexing L.P.	1,635	$0.20M	0.0%	+26.4%	0.002%
10/25/2024	New York State Teachers Retirement System	78,175	$9.76M	0.0%	+2.5%	0.083%
10/25/2024	Highview Capital Management LLC DE	1,972	$0.25M	0.1%	N/A	0.002%
10/25/2024	China Universal Asset Management Co. Ltd.	18,342	$2.29M	0.3%	+65.2%	0.019%
10/25/2024	abrdn plc	431,098	$53.94M	0.1%	+30.7%	0.456%
10/24/2024	Nisa Investment Advisors LLC	1,070	$0.13M	0.0%	+16.9%	0.001%
10/24/2024	Riggs Asset Managment Co. Inc.	2,300	$0.29M	0.1%	+666.7%	0.002%
10/24/2024	State of Alaska Department of Revenue	11,035	$1.38M	0.0%	+7.3%	0.012%
10/24/2024	Valley National Advisers Inc.	225	$28K	0.0%	-35.9%	0.000%
10/24/2024	Wealth Enhancement Advisory Services LLC	4,481	$0.56M	0.0%	-10.0%	0.005%
10/24/2024	PFG Investments LLC	26,674	$3.33M	0.2%	+8.7%	0.028%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	6,002	$0.75M	0.0%	+112.7%	0.006%
10/23/2024	Louisiana State Employees Retirement System	26,400	$3.30M	0.1%	-1.1%	0.028%
10/23/2024	Values First Advisors Inc.	471	$59K	0.0%	N/A	0.000%
10/23/2024	Assenagon Asset Management S.A.	350,052	$43.72M	0.1%	-2.7%	0.370%

Data available starting January 2016

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with duchenne with a confirmed mutation in the duchenne gene. The company is also developing SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Genevant Sciences; University of Florida; Dyno Therapeutics; Hansa Biopharma; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $109.71

$109.26

$110.20

50 Day Range

MA: $122.50

$104.54

$132.02

52 Week Range

Now: $109.71

$78.67

$173.25

Volume

17,157 shs

Average Volume

1,228,453 shs

Market Capitalization

$10.48 billion

P/E Ratio

87.77

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Sarepta Therapeutics?: Sarepta Therapeutics' top insider investors include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Ryan Edward Brown (EVP)
Kathryn Jean Boor (Director)
Stephen Mayo (Director)
Learn More about top insider investors at Sarepta Therapeutics.
Who are the major institutional investors of Sarepta Therapeutics?: Sarepta Therapeutics' top institutional shareholders include:
Janus Henderson Group PLC — 4.56%
Wellington Management Group LLP — 2.85%
Geode Capital Management LLC — 1.78%
Jacobs Levy Equity Management Inc. — 0.79%
Erste Asset Management GmbH — 0.67%
Alkeon Capital Management LLC — 0.66%
Learn More about top institutional investors of Sarepta Therapeutics stock.
Which institutional investors are selling Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was sold by these institutional investors:
Braidwell LP
Two Sigma Advisers LP
Ikarian Capital LLC
Principal Financial Group Inc.
LMR Partners LLP
Walleye Trading LLC
Eagle Asset Management Inc.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
During the previous year, company insiders that have sold Sarepta Therapeutics company stock include:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Ian Michael Estepan (CFO)
Bilal Arif (Insider)
Hans Lennart Rudolf Wigzell (Director)
Dallan Murray (Insider)
Learn More investors selling Sarepta Therapeutics stock.
Which institutional investors are buying Sarepta Therapeutics stock?: During the previous quarter, SRPT stock was bought by institutional investors including:
Wellington Management Group LLP
Erste Asset Management GmbH
Janus Henderson Group PLC
Soros Fund Management LLC
Summit Partners Public Asset Management LLC
abrdn plc
Bellevue Group AG
Simplify Asset Management Inc.
Within the last year, these company insiders have bought Sarepta Therapeutics stock:
Douglas S Ingram (CEO)
Michael Andrew Chambers (Director)
Richard Barry (Director)
Learn More investors buying Sarepta Therapeutics stock.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.